Study guide

7.2 Strain Acquisition, Tracking Quality, and Reproducibility

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

7.2 Strain Acquisition, Tracking Quality, and Reproducibility

Key Takeaways Explain This Topic AI

GLS measures longitudinal myocardial deformation and conventionally retains a negative sign for systolic shortening.

Nonforeshortened A4C, A2C, and apical long-axis loops, complete myocardium, useful frame rate, and clean ECG are prerequisites for reliable tracking.

Every segment must be visually checked through the cardiac cycle because smoothing, curves, and polar maps can conceal tracking of cavity, pericardium, or artifact.

Serial comparison is strongest with matched physiology and acquisition, the same vendor and software release, saved raw loops, and documented exclusions and limitations.

Last updated: July 2026

Strain begins with deformation and convention

Strain describes change in length relative to the original length. Longitudinal systolic shortening is conventionally negative, so a segment that shortens from its end-diastolic length has negative longitudinal strain. Global longitudinal strain, or GLS, summarizes longitudinal deformation across the analyzed LV segments; it is not ejection fraction expressed with another unit. Retain the negative sign in display and reporting unless the laboratory explicitly reports the absolute magnitude and labels it as global longitudinal shortening. A value that is less negative represents less shortening, but interpretation requires loading, rhythm, image quality, software, and clinical context.

Speckle-tracking echocardiography follows acoustic patterns frame to frame. It is angle independent in principle but not image independent: dropout, reverberation, lateral resolution, out-of-plane motion, and foreshortening can make software follow the wrong feature. Current ASE guidance favors two-dimensional speckle tracking for comprehensive clinical LV GLS. Tissue-Doppler-derived strain remains more angle dependent and is not interchangeable with speckle-tracking GLS.

Acquire comparable apical loops

Acquire nonforeshortened apical four-chamber, two-chamber, and long-axis views that include the entire LV myocardium. The true apex should be beyond the cavity's long axis, not a rounded cap created by an overly high window. Keep depth just sufficient for the LV, narrow the sector without cutting off myocardium, center the ventricle, optimize focus and frequency, and balance gain so endocardium is visible without filling the wall with noise. Record a clean ECG because beat selection and valve-event timing depend on it.

Use the laboratory and vendor protocol for frame rate. A larger sector and greater depth reduce frame rate; an extremely high rate obtained by sacrificing spatial information may also impair tracking. Save native tissue loops before contrast when the protocol requires it, because contrast interfaces can alter tracking. Record heart rate, rhythm, blood pressure, and relevant loading conditions. For serial studies, reproduce patient position, view geometry, acquisition settings, beat selection, and physiologic conditions as closely as practical.

Acquisition problem What it does Best technical response

Foreshortened apex Changes LV length and segment deformation Reposition to the true apical window and reacquire all required views

Endocardial dropout Invites tracking into cavity, pericardium, or artifact Adjust window, frequency, gain, and focus; use another interspace if needed

Low frame rate Misses rapid motion and reduces temporal tracking Reduce depth or sector width while retaining the entire myocardium

Very narrow sector that clips wall Excludes required segments despite a higher rate Widen enough to include the complete myocardial ROI

Ectopy or variable cycle length Produces beat-dependent strain and timing Select protocol-defined representative beats and document the rhythm limitation

In atrial fibrillation, a single attractive loop may not be representative. Use the laboratory's validated beat-selection or averaging method, seek comparable preceding and pre-preceding intervals when applicable, and document variability. Do not substitute a postectopic beat merely because its border is clearer; altered filling and contractility change deformation.

Verify tracking rather than trusting the bull's-eye

Select end-diastole and end-systole consistently. Aortic-valve closure can be derived from the apical long-axis view, Doppler, or a validated automatic method, but the same method should support comparison. Trace the endocardial contour at the software-defined reference frame, then adjust the region of interest to contain the full myocardial wall while excluding blood pool, pericardium, papillary muscles, and adjacent structures. Current ASE guidance generally reports midwall strain.

Play the tracking overlay through the entire cardiac cycle and compare it directly with myocardial motion in every segment. A smooth curve or complete polar map does not prove validity; software smoothing can hide tracking failure. If a basal segment follows pericardium, the contour jumps into the cavity, or the apex slips out of plane, correct the contour and region. Reacquire when image information is insufficient. Reject an uncorrectable segment according to the validated software and laboratory rule rather than accepting it to make the map complete.

GLS is a global measure, while regional segment values and patterns are less reproducible and more vulnerable to local artifact. Review the curves, timing, tracking overlay, and source loops before accepting the number. Dyskinetic lengthening may generate positive systolic strain; do not remove the sign merely to make all segments look alike. The sonographer documents the acquisition and analysis quality, while the interpreting physician integrates the result with function, loading, and disease.

Design serial studies for reproducibility

Use the same vendor and, ideally, the same software release for serial measurements. Vendors have improved agreement for global values, but algorithms, border conventions, and regional results can still differ. An apparent change after an upgrade, different platform, major blood-pressure change, or different rhythm is not automatically biologic. Save raw loops, record the platform and analysis version when available, and state excluded segments or limited views.

For surveillance, first compare technical comparability: views, frame rate, rhythm, loading, timing convention, ROI, tracking acceptance, and software. Only then compare GLS. If a patient's blood pressure is markedly higher and two segments track poorly, reacquisition and transparent limitation are more defensible than reporting a precise delta. Reproducibility is produced by a controlled workflow, not by copying the prior value or adjusting contours until the new result matches it.

Watch the myocardium, not just the curves

Review the tracking overlay through the full cardiac cycle in every view. A smooth curve and colorful polar map can still be generated when the contour follows cavity, pericardium, or out-of-plane artifact.